Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$118.97

-5.03 (-4.06%)

06:54
03/26/19
03/26
06:54
03/26/19
06:54

Sarepta gene therapy update a 'slight positive' for shares, says Citi

Sarepta Therapeutics' Duchenne muscular dystrophy gene therapy update yesterday on four patients through 270 day is a "slight positive" for the stock as no major unexpected red flags emerged, Citi analyst Joel Beatty tells investors in a research note titled "No Bad News from DMD Gene Therapy Data Update Is Good News." Shares of Sarepta closed yesterday down $3.34 to $118.92. However, the analyst says the incremental functional and biomarker data do not add to his conviction because he views these endpoints as inherently difficult to assess in an uncontrolled trial. Nonetheless, Beatty continues to find the previously announced micro-dystrophin expression data as the "most convincing and meaningful piece of data for this agent." He keeps a Buy rating on Sarepta with a $201 price target.

  • 19

    Aug

SRPT Sarepta
$118.97

-5.03 (-4.06%)

03/25/19
JPMS
03/25/19
NO CHANGE
JPMS
Overweight
Data today reinforce Sarepta's 'pole position,' says JPMorgan
The updated data from the first four Duchenne muscular dystrophy patients of Sarepta Therapeutics' Phase 1/2 trial at nine months are "all directionally positive" on both biomarker and functional assessments, JPMorgan analyst Anupam Rama tells investors in a research note. The analyst is not surprised with the creatine kinase fluctuations as patients become more active and finds it important that all biomarker/functional endpoints were improved from baseline at nine months. While lingering questions about competition in the micro-dystrophin space remain, these data reinforce Sarepta's "pole position," Rama contends. He keeps an Overweight rating on the shares. The stock in morning trading is down 4%, or $4.53, to $117.73.
03/25/19
RBCM
03/25/19
NO CHANGE
Target $192
RBCM
Outperform
Sarepta data does not change thesis on DMD program, says RBC Capital
RBC Capital analyst Brian Abrahams notes that Sarepta Theraputics this morning reported nine-month functional and creatine kinase data from baseline from the four patients in the Phase 1 open-label study of the company's micro-dystrophin gene therapy candidate for Duchenne muscular dystrophy. Overall, Abrahams says the results show continued improvements in North Star Ambulatory Assessment functional scores vs. the baseline, and that while the update may not stop concerns, it does not change his overall thesis on the program, where he continues to believe the totality of expression, biomarker and functional data point to real benefits that should enable improvements supporting approval in ongoing/subsequent studies. Abrahams, who has an Outperform rating and $192 price target on Sarepta, says he would use weakness as a buying opportunity.
03/25/19
NEED
03/25/19
NO CHANGE
Target $196
NEED
Buy
Sarepta treatment shows 'impressive' improvement at 9 months, says Needham
After Sarepta presented updated 9 month data from four boys in a study testing their micro-dystrophin gene therapy, Needham analyst Chad Messer said "impressive" functional improvement was observed in all four patients and that levels of creatinine kinase, which is a measure of muscle damage, were generally improved and below levels normally associated with Duchenne. Messer maintains a Buy rating and $196 price target on Sarepta shares.
03/25/19
PIPR
03/25/19
NO CHANGE
PIPR
Overweight
Piper stays bullish on Sarepta, says CK spikes 'not worrisome'
Piper Jaffray analyst Danielle Brill reiterates an Overweight rating on Sarepta Therapeutics provided a nine-month update for all four patients in its Phase 1 microdystrophin gene therapy trial. Results showed "marked improvements" in the NorthStar Ambulatory Assessment for all patients while creatine kinase level spikes were also observed, Brill tells investors in a research note. The analyst attributes the CK spikes to spikes to physical exertion and finds them "not worrisome." CK levels trended down for patients and the functional data continue to look encouraging, Brill contends. She stays bullish on Sarepta shares. The stock in afternoon trading is down 2%, or $2.99, to $119.27.

TODAY'S FREE FLY STORIES

ILKAY

Iluka Resources

$0.00

(0.00%)

04:48
05/24/19
05/24
04:48
05/24/19
04:48
Upgrade
Iluka Resources rating change  »

Iluka Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WOLWF

Woolworths Group

$0.00

(0.00%)

04:47
05/24/19
05/24
04:47
05/24/19
04:47
Downgrade
Woolworths Group rating change  »

Woolworths Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNVGY

Lenovo

$0.00

(0.00%)

04:45
05/24/19
05/24
04:45
05/24/19
04:45
Upgrade
Lenovo rating change  »

Lenovo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:00
05/24/19
05/24
04:00
05/24/19
04:00
General news
FX Action: The Canadian dollar found a toehold »

FX Action: The Canadian…

03:05
05/24/19
05/24
03:05
05/24/19
03:05
General news
FX Update: The dollar, yen and Swiss franc have softened »

FX Update: The dollar,…

02:50
05/24/19
05/24
02:50
05/24/19
02:50
General news
China's Treasury holdings back in focus »

China's Treasury…

01:55
05/24/19
05/24
01:55
05/24/19
01:55
General news
Asian Market Wrap: 10 »

Asian Market Wrap:…

LNVGY

Lenovo

$0.00

(0.00%)

20:51
05/23/19
05/23
20:51
05/23/19
20:51
Upgrade
Lenovo rating change at Goldman Sachs »

Lenovo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$128.68

-7.12 (-5.24%)

20:46
05/23/19
05/23
20:46
05/23/19
20:46
Recommendations
Splunk analyst commentary at MUFG »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Jun

  • 09

    Jul

FIS

FIS

$120.45

-0.59 (-0.49%)

, FISV

Fiserv

$87.23

-2.4 (-2.68%)

20:25
05/23/19
05/23
20:25
05/23/19
20:25
Conference/Events
Cantor Fitzgerald technology analyst to hold an analyst/industry conference call »

Technology Analyst Foresi…

FIS

FIS

$120.45

-0.59 (-0.49%)

FISV

Fiserv

$87.23

-2.4 (-2.68%)

GPN

Global Payments

$147.97

-2.64 (-1.75%)

IMXI

International Money Express

$13.32

-0.18 (-1.33%)

JKHY

Jack Henry

$132.23

-3.43 (-2.53%)

MA

MasterCard

$249.83

-7.07 (-2.75%)

PYPL

PayPal

$109.91

-2.56 (-2.28%)

SQ

Square

$63.72

-2.53 (-3.82%)

V

Visa

$161.52

-2.72 (-1.66%)

WP

Worldpay

$121.97

-0.48 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 18

    Jun

  • 25

    Jun

  • 01

    Aug

  • 13

    Nov

20:25
05/23/19
05/23
20:25
05/23/19
20:25
Conference/Events
Morgan Stanley China telecom director to hold analyst/industry conference call »

China Telecom & Media…

FL

Foot Locker

$52.85

-1.355 (-2.50%)

20:25
05/23/19
05/23
20:25
05/23/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

ROYMY

Royal Mail

$0.00

(0.00%)

20:02
05/23/19
05/23
20:02
05/23/19
20:02
Upgrade
Royal Mail rating change at Goldman Sachs »

Royal Mail upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRAY

Cray

$35.18

-0.18 (-0.51%)

, HPE

HP Enterprise

$14.33

-0.21 (-1.44%)

20:00
05/23/19
05/23
20:00
05/23/19
20:00
Downgrade
Cray, HP Enterprise rating change at KeyBanc »

Cray downgraded to Sector…

CRAY

Cray

$35.18

-0.18 (-0.51%)

HPE

HP Enterprise

$14.33

-0.21 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 28

    May

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 11

    Jun

  • 09

    Jul

AVP

Avon Products

$3.61

-0.46 (-11.30%)

19:57
05/23/19
05/23
19:57
05/23/19
19:57
Downgrade
Avon Products rating change at DA Davidson »

Avon Products downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSKY

GreenSky

$10.74

-0.24 (-2.19%)

, RF

Regions Financial

$14.08

-0.325 (-2.26%)

19:42
05/23/19
05/23
19:42
05/23/19
19:42
Hot Stocks
GreenSky CEO says recent volatility created opportunity to accelerate buybacks »

CEO David Zalik says:…

GSKY

GreenSky

$10.74

-0.24 (-2.19%)

RF

Regions Financial

$14.08

-0.325 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 11

    Jun

UBER

Uber

$40.46

-0.63 (-1.53%)

19:17
05/23/19
05/23
19:17
05/23/19
19:17
Periodicals
Uber to roll out JUMP electric bike service in London, Reuters says »

Uber will bring its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

AMZN

Amazon.com

$1,815.30

-42.44 (-2.28%)

19:07
05/23/19
05/23
19:07
05/23/19
19:07
Hot Stocks
Amazon launches support for traditional Chinese books on Kindle »

Amazon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 25

    Jun

LM

Legg Mason

$36.91

-0.25 (-0.67%)

19:00
05/23/19
05/23
19:00
05/23/19
19:00
Periodicals
Legg Mason to cut 12% of its workforce, FT reports »

Legg Mason plans to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGTX

TG Therapeutics

$7.12

0.22 (3.19%)

18:57
05/23/19
05/23
18:57
05/23/19
18:57
Hot Stocks
TG Therapeutics CEO: We're a bit of an unconventional company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

SQM

SQM

$30.86

-1.82 (-5.57%)

18:57
05/23/19
05/23
18:57
05/23/19
18:57
Downgrade
SQM rating change at BMO Capital »

SQM downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SQM

SQM

$30.86

-1.82 (-5.57%)

18:51
05/23/19
05/23
18:51
05/23/19
18:51
Downgrade
SQM rating change at BMO Capital »

SQM downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

, DECK

Deckers Brands

$147.27

-2.94 (-1.96%)

18:50
05/23/19
05/23
18:50
05/23/19
18:50
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Viasat…

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

DECK

Deckers Brands

$147.27

-2.94 (-1.96%)

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

INTU

Intuit

$241.30

-6.22 (-2.51%)

NVCR

Novocure

$49.40

-1.92 (-3.74%)

CTL

CenturyLink

$9.66

-0.29 (-2.91%)

ADSK

Autodesk

$169.64

-4.47 (-2.57%)

LGF.A

Lionsgate

$15.96

-0.06 (-0.37%)

ROST

Ross Stores

$94.54

-0.06 (-0.06%)

SPLK

Splunk

$128.68

-7.12 (-5.24%)

HPE

HP Enterprise

$14.33

-0.21 (-1.44%)

DVAX

Dynavax

$6.36

(0.00%)

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 10

    Jun

  • 12

    Jun

  • 13

    Jun

  • 17

    Jun

  • 09

    Jul

EPE

EP Energy

$0.16

(0.00%)

18:32
05/23/19
05/23
18:32
05/23/19
18:32
Hot Stocks
EP Energy suspends NYSE trading, begins trading on OTC markets »

EP Energy confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$76.07

-0.28 (-0.37%)

, NFLX

Netflix

$352.23

-7.47 (-2.08%)

18:15
05/23/19
05/23
18:15
05/23/19
18:15
Hot Stocks
T-Mobile says new Magenta plan will include Netflix Basic for families »

T-Mobile (TMUS) said…

TMUS

T-Mobile

$76.07

-0.28 (-0.37%)

NFLX

Netflix

$352.23

-7.47 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 03

    Jun

  • 06

    Jun

  • 13

    Jun

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.